Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: Extended efficacy of T cell vaccine therapy

Journal of Immunology

Volumn 192, Issue 9, 2014, Pages 4093-4102

  Zang, Yunjuan ^a   Martinez, Laisel ^b   Fernandez, Irina ^c   Pignac Kobinger, Judith ^a   Greidinger, Eric L ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Miami VA Foundation for Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RIBONUCLEOPROTEIN T LYMPHOCYTE VACCINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL SELECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; GENETIC CONSERVATION; HUMORAL IMMUNITY; HYBRIDOMA; IMMUNOPATHOGENESIS; LUPUS VULGARIS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NEPHRITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REMISSION; SEQUENCE HOMOLOGY; VACCINATION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; RIBONUCLEOPROTEINS; T-LYMPHOCYTES; VACCINES;

EID: 84899511963     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203197     Document Type: Article

References (24)

1. Tucker, L. B., S. Menon, J. G. Schaller, and D. A. Isenberg. 1995. Adult- and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Br. J. Rheumatol. 34: 866-872
2. Kirou, K. A., C. Lee, S. George, K. Louca, M. G. Peterson, and M. K. Crow. 2005. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52: 1491-1503
3. Hoffman, R. W., T. Gazitt, M. F. Foecking, R. A. Ortmann, M. Misfeldt, R. Jorgenson, S. L. Young, and E. L. Greidinger. 2004. U1 RNA induces innate immunity signaling. Arthritis Rheum. 50: 2891-2896
4. Greidinger, E. L., Y. Zang, L. Martinez, K. Jaimes, M. Nassiri, P. Bejarano, G. N. Barber, and R. W. Hoffman. 2007. Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs. Arthritis Rheum. 56: 1589-1597
5. Greidinger, E. L., Y. Zang, K. Jaimes, S. Hogenmiller, M. Nassiri, P. Bejarano, G. N. Barber, and R. W. Hoffman. 2006. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum. 54: 661-669
6. Greidinger, E. L., Y. Zang, I. Fernandez, M. Berho, M. Nassiri, L. Martinez, and R. W. Hoffman. 2009. Tissue targeting of anti-RNP autoimmunity: Effects of T cells and myeloid dendritic cells in a murine model. Arthritis Rheum. 60: 534-542
7. Gall, A., P. Treuting, K. B. Elkon, Y. M. Loo, M. Gale, Jr., G. N. Barber, and D. B. Stetson. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36: 120-131
8. Fatenejad, S., M. J. Mamula, and J. Craft. 1993. Role of intermolecular/ intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90: 12010-12014
9. Greidinger, E. L., Y. J. Zang, K. Jaimes, L. Martinez, M. Nassiri, and R. W. Hoffman. 2008. CD4+ T cells target epitopes residing within the RNAbinding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J. Immunol. 180: 8444-8454
10. Trivedi, S., Y. Zang, S. Culpepper, E. Rosenbaum, I. Fernandez, L. Martinez, R. W. Hoffman, and E. L. Greidinger. 2010. T cell vaccination therapy in an induced model of anti-RNP autoimmune glomerulonephritis. Clin. Immunol. 137: 281-287
11. Muller, S., F. Monneaux, N. Schall, R. K. Rashkov, B. A. Oparanov, P. Wiesel, J. M. Geiger, and R. Zimmer. 2008. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial. Arthritis Rheum. 58: 3873-3883
12. Greidinger, E. L., M. F. Foecking, S. Ranatunga, and R. W. Hoffman. 2002. Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70- kd molecule. Arthritis Rheum. 46: 1264-1269
13. Greidinger, E. L., M. F. Foecking, K. R. Schäfermeyer, C. W. Bailey, S. L. Primm, D. R. Lee, and R. W. Hoffman. 2002. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J. Immunol. 169: 3429-3437
14. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143: 1822-1825
15. Hoffman, R. W., L. J. Rettenmaier, Y. Takeda, J. E. Hewett, I. Pettersson, U. Nyman, A. M. Luger, and G. C. Sharp. 1990. Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum. 33: 666-673
16. van Der Fits, L., Y. Sandberg, N. Darzentas, W. H. Zoutman, D. Tielemans, I. L. Wolvers-Tettero, M. H. Vermeer, and A. W. Langerak. 2011. A restricted clonal T-cell receptor ab repertoire in Sézary syndrome is indicative of superantigenic stimulation. Br. J. Dermatol. 165: 78-84
17. Simone, E., D. Daniel, N. Schloot, P. Gottlieb, S. Babu, E. Kawasaki, D. Wegmann, and G. S. Eisenbarth. 1997. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc. Natl. Acad. Sci. USA 94: 2518-2521
18. Crawford, F., B. Stadinski, N. Jin, A. Michels, M. Nakayama, P. Pratt, P. Marrack, G. Eisenbarth, and J. W. Kappler. 2011. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc. Natl. Acad. Sci. USA 108: 16729-16734
19. Boitel, B., M. Ermonval, P. Panina-Bordignon, R. A. Mariuzza, A. Lanzavecchia, and O. Acuto. 1992. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxinDerived peptide: Evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J. Exp. Med. 175: 765-777
20. Page, N., F. Gros, N. Schall, M. Décossas, D. Bagnard, J. P. Briand, and S. Muller. 2011. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus. Ann. Rheum. Dis. 70: 837-843
21. Mohan, J. F., and E. R. Unanue. 2012. Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat. Rev. Immunol. 12: 721-728
22. Namjou, B., P. H. Kothari, J. A. Kelly, S. B. Glenn, J. O. Ojwang, A. Adler, M. E. Alarcón-Riquelme, C. J. Gallant, S. A. Boackle, L. A. Criswell, et al. 2011. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 12: 270-279
23. Zimmer, R., H. R. Scherbarth, O. L. Rillo, J. J. Gomez-Reino, and S. Muller. 2013. Lupuzor/P140 peptide in patients with systemic lupus erythematosus: A randomised, double-blind, placebo-controlled phase IIb clinical trial. Ann. Rheum. Dis. 72: 1830-1835
24. Zang, Y. C., J. Hong, V. M. Rivera, J. Killian, and J. Z. Zhang. 2000. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J. Immunol. 164: 4011-4017